The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe.
An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.
U.S. health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans currently taking them.
The Taiwan Fund for Children and Families (TFCF, 家扶基金會) yesterday published research on disadvantaged children in Taiwan, revealing that ten percent of them have seen illegal drugs, over 40 percent of them cannot afford breakfast every day and 61 percent don't have someone at home to help them with their homework.
The U.S. Food and Drug Administration (FDA) announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the leading U.S. pediatrician's group, which recommends scaling back use of the medicine.
Governments have agreed the first international standards limiting cancer-causing arsenic pollution in rice, a key move to protect consumers of what is a staple food for billions, the U.N. said Thursday.
Some childhood vaccines are linked to serious side effects, but they are quite rare and do not include autism, food allergies or cancer, said a review of scientific literature Tuesday.
The Food and Drug Administration on Friday approved a new antibiotic from Cubist Pharmaceuticals to treat common skin infections often acquired in hospital.
By unleashing the immune system to attack skin cancer, researchers have made important strides against melanoma, according to the results of three clinical trials released Monday.